comparemela.com
  1. Home
  2. Live Updates
  3. Biophysical Research - Breaking News

Latest Breaking News On - Biophysical research - Page 4 : comparemela.com

Study finds traditional Japanese food may hold building blocks of COVID-19 treatments

Study finds traditional Japanese food may hold building blocks of COVID-19 treatments
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United statesTetsuya mizutaniBiophysical research communicationsPrevention researchTokyo university of agricultureBiophysical researchInfectious disease epidemiologyTokyo universityஒன்றுபட்டது மாநிலங்களில்உயிர் இயற்பியல் ஆராய்ச்சி தகவல்தொடர்புகள்ப்ரெவெந்ஶந் ஆராய்ச்சிஉயிர் இயற்பியல் ஆராய்ச்சிதொற்று நோய் தொற்றுநோய்டோக்கியோ பல்கலைக்கழகம்

Traditional Japanese food may hold building blocks of COVID-19 treatments

Traditional Japanese food may hold building blocks of COVID-19 treatments
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Koji nishifujiYutaka nibuWen rongduoAkatsuki saitoTetsuya mizutaniKyoko satoTamaki okabayashiMami obaTomoko yokotaJunko yasuokaPrevention researchEducation centerDepartment of veterinary scienceNational institute of technologyPrevention research cepiBiophysical research communications

New drug candidate may reduce anxiety-like behavior in mice

New drug candidate may reduce anxiety-like behavior in mice Anxiety, commonly termed as a feeling of fear, dread, and restlessness, is a perfectly normal reaction to stressful situations. However, a state of heightened anxiety, which is the reality for thousands of people who struggle to cope with these feelings, is called anxiety disorder. Anxiety disorder can invoke debilitating fear or apprehension, even without any immediate threat. Though intensive research over the years has yielded a plethora of information, and effective drugs like selective serotonin reuptake inhibitors have been used to alleviate this condition, a lot remains to be understood about this complex condition and its treatment.

Akiyoshi saitohEmily hendersonBiophysical research communicationsFaculty of pharmaceutical sciencesTokyo university of scienceUniversity of tsukubaTokyo universityBiophysical researchProfessor akiyoshi saitohPharmaceutical sciencesProfessor saitohஎமிலி ஹென்டர்சன்உயிர் இயற்பியல் ஆராய்ச்சி தகவல்தொடர்புகள்ஆசிரிய ஆஃப் மருந்து அறிவியல்டோக்கியோ பல்கலைக்கழகம் ஆஃப் அறிவியல்பல்கலைக்கழகம் ஆஃப் ட்சூகுபா

» Celltrion : 1ers résultats positifs d un essai mondial de Phase III sur le regdanvimab, un traitement par anticorps monoclonal anti-COVID-19 MyPharma Editions

» Celltrion : 1ers résultats positifs d un essai mondial de Phase III sur le regdanvimab, un traitement par anticorps monoclonal anti-COVID-19 MyPharma Editions
mypharma-editions.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mypharma-editions.com Daily Mail and Mail on Sunday newspapers.

South africaSouth africanBiophysical researchPhase iiiJune sourceஉயிர் இயற்பியல் ஆராய்ச்சிகட்டம் ஈயீஜூன் மூல

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo

ALG-097111 potently inhibits SARS-CoV-2 replication in Syrian Hamster model in vivo Antiviral drugs have been proven successful as a therapeutic approach to inhibit HCV and HIV viral proteases. With the coronavirus disease 2019 (COVID-19) pandemic causing unprecedented morbidity and mortality, there is an urgent need for effective antivirals to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, scientists across the world have been trying to repurpose existing antivirals designed to treat other viruses. Remdesivir, a nucleotide analog that inhibits the nsp12 polymerase and originally developed for Ebola, was approved to treat SARS (or SARS-CoV-1) as a result of these drug repurposing efforts. Another nsp12 inhibitor, MK-4482/EIDD-2801, is currently being assessed for use in SARS-CoV-2 therapy.

Juan gaertner shutterstockSusha cheriyedathBiophysical research communicationsSyrian hamsterJuan gaertnerBiophysical researchCoronavirus disease covid 19N vivoArs cov 2Drug repurposingN vitroEvere acute respiratoryEvere acute respiratory syndromeஉயிர் இயற்பியல் ஆராய்ச்சி தகவல்தொடர்புகள்சிரிய வெள்ளெலிஜுவான் கேர்ட்னெற்

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.